skip to Main Content

Cancer Services

Lung Cancer

Please see below all current lung cancer clinical trials of the Central Coast Cancer Centre.

Medical oncology clinical trials

Name: N/A

A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects with Advanced Non-small Cell Lung Cancer.

Protocol Number: D4190C00006
Principal Investigator: Dr Matthew Chan
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Lung Cancer
External page link More information on this trial

Name: MYSTIC

A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination with Tremelimumab Therapy or MEDI4736 Monotherapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC).

Protocol Number: D419AC00001
Principal Investigator: Dr Matthew Chan
Study Coordinator: Michelle Dixon
Status: Recruitment closed
Condition: Lung Cancer
External page link More information about MYSTIC

Name: BR31

A phase 3 prospective double blind placebo controlled randomized study of adjuvant medi4736 in completely resected non-small cell lung cancer.

Protocol Number: BR31
Principal Investigator: Dr Matthew Chan
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Lung Cancer
External page link More information about BR31

Name: ALTA

A Randomized Phase 2 Study of AP26113 in Patients with ALK-positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated with Crizotinib.

Protocol Number: AP26113-13-201
Principal Investigator: Dr Matthew Wong
Study Coordinator: Leonie Kelly
Status: Recruitment closed
Condition: Lung Cancer
External page link More information about ALTA

Name: PivOTAL

Global treatment Patterns, resource utilization and biomarker Testing in Advanced non-small cell Lung cancer.

Protocol Number: MK3475-3396
Principal Investigator: Dr Matthew Chan
Study Coordinator: Michelle Dixon
Status: Recruitment closed
Condition: Lung Cancer

Name: DETERMINE

A Phase 2, Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Second- or Third-line Treatment of Subjects with Unresectable Pleural or Peritoneal Malignant Mesothelioma
Protocol Number: D488OC00003
Principal Investigator: Dr Susan Tiley
Study Coordinator: Leonie Kelly
Status: Closed
Condition: Lung cancer
External page link More information about DETERMINE

Radiation oncology clinical trials

Name: SABR

A Phase II Study of Stereotactic Ablative Body Radiotherapy (SABR) for Stage I NSCLC
Protocol Number: SSBROC 002
Principal Investigator: Dr Maria Azzi
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Lung cancer
External page link More information about SABR

Name: P-Lung

A Randomised phase III trial of high dose Palliative Radiotherapy (HDPRT) versus concurrent Chemotherapy + HDPRT (C-HDPRT) in patients with good performance status, locally advanced / small volume metastatic NSCLC not suitable for radical Chemoradiotherapy
Protocol Number: TROG 11.03
Principal Investigator: Dr Maria Azzi
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Lung Cancer
External page link More information about P-Lung

More information

For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 3940 or see:

Internal page Research and Clinical Trials

Back To Top